FedEx Shorts Build Amid Rising Retail Attention Before Tuesday's Print

Retail attention for FDX spiked 2.5 standard deviations above its 90-day average on October 23, per Wikipedia views and ORTEX stock page traffic. Short positioning has risen 7.5% over the past month to 2.21% of free float, while the stock itself is up 2.8% over the past week, well ahead of the median for its closest peers.

Where FDX Sits Among Peers

Among the air freight and logistics names ORTEX tracks, FDX is not the most crowded short. Positioning at 2.21% of float is moderate by sector standards. UPS gained 3.8% over the past week, broadly in line with FDX. GXO added 5.1% over the same period, making it the clearest outperformer in the immediate peer set. The shared upward drift suggests macro conditions are broadly supportive across the sector right now, not a story specific to FDX.

Short Positioning: A Month of Accumulation

Shorts added roughly 728,000 shares over October, pushing the estimated short position up 7.5% on the month. That build came despite the stock rising. On the day-to-day trend the position has started to ease: shares short fell 4.4% over the past week, from around 5.46 million to 5.22 million.

Borrow is no constraint. Availability remains at the maximum reading in the dataset, with 236 million shares lent out of a pool that dwarfs current short demand. Cost to borrow sits at 0.36%, a multi-month low, well below the 0.49% seen in early September. Any short seller wanting to add exposure faces no friction at all from the lending market.

Earnings in Five Days

FDX reports on October 28. The last print, in late September, produced a one-day move of just 0.6%. The print before that, in June, saw the stock fall 3.6%. The options market is modestly put-skewed: the put-call ratio of 0.89 is above its 20-day mean of 0.85, a z-score of 1.1, not an extreme reading but directionally noteworthy with the event so close.

Analysts are broadly constructive. Citigroup raised its target to $373 on October 7. JP Morgan kept its Overweight rating with a $399 target. The consensus mean sits at $355.88 against a current price of $303.92, implying roughly 17% upside on analyst estimates. The EPS momentum rank stands at the 85th percentile over the past 30 days.

ORTEX also flags a 55% probability that FDX sees a share-count increase in the CRSP US Mid index at the December 2026 Quarterly Review, which would require tracker buying of around $648 million, equivalent to 1.4 days of normal trading volume, with the rank date on December 4.

What Changes the Picture

The one level worth watching is the 30-day short position trend. A month of accumulation that is now starting to reverse, combined with a stock that has quietly outperformed peers, sets a different backdrop heading into Tuesday's print than the headline build suggests. If the result prompts further short covering, the borrow market poses no obstacle: availability is as loose as it gets.

---

Data summary

• SI % FF: 2.21% (month-ago: ~2.06%)
• 1-week SI change: -4.4%
• 1-month SI change: +7.5%
• Cost to borrow: 0.36% (September high: 0.49%)
• Availability: maximum reading; 236M shares in pool
• Retail attention z-score: 2.5 (as of October 23)
• Next earnings: October 28
• Analyst mean target: $355.88 vs price $303.92